iTeos Therapeutics, Inc. (ITOS) - Yahoo Finance

Find the latest iTeos Therapeutics, Inc. (ITOS) stock quote, history, news and other vital information to help you with your stock trading and investing.

$25.00
OFF

ITeos Therapeutics (NASDAQ:ITOS) Earns "Buy" Rating From

1 week from now

1 day ago · Wedbush reissued an "outperform" rating and issued a $25.00 target price on shares of iTeos Therapeutics in a report on Friday, January 10th. View Our Latest Research Report …

marketbeat.com

$21.00
OFF

ITeos Therapeutics: Promising Phase 2 Data Boosts Buy Rating On …

1 week from now

1 day ago · H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report) today and set a price target of $21.00. Discover …

businessinsider.com

34%
OFF

ITOS P/E Ratio: Current & Historical Analysis - Public.com

1 week from now

2 days ago · The P/E ratio for ITOS is -2.47 as of Jan 15, 2025.This represents a decrease of-35.34% compared to its 12-month average P/E ratio of-3.82.A higher P/E ratio suggests that …

public.com

$86621
OFF

Kreg Therapeutics, Inc. Careers In North Bergen, NJ

1 week from now

Kreg Therapeutics, Inc. salaries in North Bergen, NJ. Salary estimated from 23 employees, users, and past and present job advertisements on Indeed. Clinic Manager. $86,621 per year. …

indeed.com

$52
OFF

HALL Structured Finance Originates A $52.5M Loan Commitment …

1 week from now

March 06, 2023 – HALL Structured Finance (HSF) announced today that the company has originated a new first lien construction loan commitment totaling $52.5 million to be used for …

hallgroup.com

FAQs about iTeos Therapeutics, Inc. (ITOS) - Yahoo Finance Coupon?

Should you buy iTeos Therapeutics (ITOS)?

Your Privacy Choices Ad Terms Feedback iTeos Therapeutics (ITOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. ...

Does iTeos Therapeutics (ITOs) have a high governance risk?

A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk. See the company profile for iTeos Therapeutics, Inc. (ITOS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation. ...

Who is iTeos Therapeutics?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. ...

What is iTeos Therapeutics' ISS governance qualityscore?

iTeos Therapeutics, Inc.’s ISS Governance QualityScore as of December 1, 2023 is 8. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 8; Compensation: 8. Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. ...